Day Zero Diagnostics
Day Zero Diagnostics is a Boston-based company pioneering infectious disease diagnostics using whole-genome sequencing and machine learning. Their mission is to revolutionize diagnosis and treatment of infectious diseases by providing rapid, comprehensive organism identification and antimicrobial resistance profiling without the need for culture, thereby enabling precision medicine and better outbreak management.
Industries
Nr. of Employees
medium (51-250)
Day Zero Diagnostics
Boston, Massachusetts, United States, North America
Products
Sample preparation method for direct-from-blood pathogen sequencing
A laboratory method to enrich and recover pathogen genomes directly from blood samples to enable whole-genome sequencing without prior culture.
Computational platform for AMR prediction from whole-genome data
A software platform that analyzes pathogen whole-genome sequences and returns predicted antimicrobial susceptibility profiles using machine learning models trained on large genome–phenotype datasets.
Sample preparation method for direct-from-blood pathogen sequencing
A laboratory method to enrich and recover pathogen genomes directly from blood samples to enable whole-genome sequencing without prior culture.
Computational platform for AMR prediction from whole-genome data
A software platform that analyzes pathogen whole-genome sequences and returns predicted antimicrobial susceptibility profiles using machine learning models trained on large genome–phenotype datasets.
Services
Rapid genomic outbreak analysis service
Laboratory and computational service that performs whole-genome sequencing and automated analysis to determine pathogen relatedness for suspected healthcare-associated infection outbreaks, with rapid turnaround intended to inform infection control decisions.
Genomic-based antimicrobial susceptibility prediction service
Computational service that uses whole-genome sequencing inputs and machine learning models to predict antimicrobial resistance and susceptibility profiles for clinical pathogens.
Rapid genomic outbreak analysis service
Laboratory and computational service that performs whole-genome sequencing and automated analysis to determine pathogen relatedness for suspected healthcare-associated infection outbreaks, with rapid turnaround intended to inform infection control decisions.
Genomic-based antimicrobial susceptibility prediction service
Computational service that uses whole-genome sequencing inputs and machine learning models to predict antimicrobial resistance and susceptibility profiles for clinical pathogens.
Expertise Areas
- Infectious disease genomics
- Antimicrobial resistance prediction
- Outbreak detection and genomic epidemiology
- Sample preparation for direct-from-sample sequencing
Key Technologies
- Whole-genome sequencing (WGS)
- Long-read sequencing
- Hybrid genome assembly (short + long reads)
- K-mer based genomic comparison algorithms